Browse > Article
http://dx.doi.org/10.5851/kosfa.2012.32.5.635

Screening and Characterization of Lactobacillus casei MCL Strain Exhibiting Immunomodulation Activity  

Choi, Jae-Kyoung (Department of Animal Science and Technology, Chung-Ang University)
Lim, Yea-Seul (Department of Animal Science and Technology, Chung-Ang University)
Kim, Hee-Jin (Department of Animal Science and Technology, Chung-Ang University)
Hong, Yeong-Ho (Department of Animal Science and Technology, Chung-Ang University)
Ryu, Buom-Yong (Department of Animal Science and Technology, Chung-Ang University)
Kim, Geun-Bae (Department of Animal Science and Technology, Chung-Ang University)
Publication Information
Food Science of Animal Resources / v.32, no.5, 2012 , pp. 635-643 More about this Journal
Abstract
As an appraisal for the application of a new starter culture, more than 200 lactic acid bacteria strains were isolated from raw milk and healthy human feces. The strains showing excellent growth and acid production ability in 10% skim milk media were selected and identified as Lactobacillus casei based on the results of their API carbohydrate fermentation patterns, as well as 16S rDNA sequence analysis. To assess the effect of L. casei strains on irritable bowel disease (IBD), the inhibitory effect of the selected strains against the nitric oxide (NO) production of lipopolysaccharide (LPS)-stimulated RAW 264.7 cells was measured. Among the tested L. casei strains, L. casei MCL was observed to have the greatest NO inhibitory activity. Additionally, L. casei MCL was found to inhibit mRNA expression of pro-inflammatory cytokines (interleukin-$1{\beta}$, IL-6, TNF-${\alpha}$), as well as cyclooxygenase-2 (COX-2) and inducible nitric oxide synthase (iNOS) involved in pathophysiologic processes such as inflammation. The mRNA expression of anti-inflammatory cytokines, including IL-10 and transforming growth factor-$1{\beta}$ (TGF-${\beta}$) of L. casei MCL, was confirmed using quantitative real-time PCR. In conclusion, L. casei MCL showed decreases in the expression of pro-inflammatory cytokines and up-regulated expression of the anti-inflammatory cytokine.
Keywords
immunomodulating; Lactobacillus casei; probiotics; cytokine;
Citations & Related Records
Times Cited By KSCI : 1  (Citation Analysis)
Times Cited By Web Of Science : 0  (Related Records In Web of Science)
연도 인용수 순위
1 Cirino, G., Distrutti, E., and Wallace, J. L. (2006) Nitric oxide and inflammation. Inflamm. Allergy Drug Target 5, 115-119.   DOI
2 Coleman, J. W. (2001) Nitric oxide in immunity and inflammation. Int. Immunopharmacol. 1, 1397-1406.   DOI   ScienceOn
3 de Waard, R., Garssen, J., Snel, J., Bokken G. C., Sako, T., Veld, J. H., and Vos, J. G. (2001) Enhanced antigen-specific delayed-type hypersensitivity and immunoglobulin G2b responses after oral administration of viable Lactobacillus casei YIT 9029 in Wister and Brown Norway rats. Clin. Diagn. Lab. Immun. 8, 762-767.
4 Food and Agriculture Organization of the United Nations. (2001) Health and nutritional properties of probiotics in food including powder milk with live lactic acid bacteria. (http://www.who.int/foodsafety/publications/fs_management/en/probiotics.pdf)
5 Fuller, R. (1993) Probiotic foods, current use and future developments. Int. Food Ingred. 3, 23-26.
6 Gilliland, S. E. and Walker, D. K. (1990) Factors to consider when selecting a culture of Lactobacillus acidophilus as a dietary adjunct to produce a hypocholesterolemic effect in humans. J. Dairy Sci. 73, 905-911.   DOI   ScienceOn
7 Hanauer, S. B. (2002) New steroids for IBD: progress report. Gut 51, 182-183.   DOI
8 Henderson, B., Poole, S., and Wilson, M. (1996) Bacterial modulins: a novel class of virulence factors which cause host tissue pathology by inducing cytokine synthesis. Microbiol. Rev. 60, 316-341.
9 Ishikawa, H., Akedo, I., Otani, T., Suzuki, T., Nakamura, T., Takeyama, I., Ishiquro, S., Miyaoka, E., Sobue, T., and Kakizoe, T. (2005) Randomized trial of dietary fiber and Lactobacillus casei administration for prevention of colorectal tumors. Int. J. Cancer 116, 762-767.   DOI   ScienceOn
10 Jeong, I. Y., Lee, H. J., Jin, C. H., Park, Y. D., Choi, D. S., and Kang, M. A. (2010) Anti-inflammatory activity of Stevia rebaudiana in LPS-induced RAW 264.7 cells. J. Food Sci. Nutr. 15, 14-18.   DOI   ScienceOn
11 Kakizoe, T. (2000) Asian studies of cancer chemoprevention: latest clinical results. Eur. J. Cancer 36, 1303-1309   DOI   ScienceOn
12 Kandler, O. and Weiss, N. (1986) Genus Lactobacillus Beijerinck 1901. In: Bergey's manual of systematic bacteriology, Vol. 2. Sneath, P. H. A., Mair, N. S., Sharpe, M. E., and Holt, J.G. (eds) Williams and Wilkins, Baltimore, pp. 1209-1234.
13 Lee, H. S., Han, S. Y., Bae, E. A., Huh, C. S., Ahn, Y. T., Lee, J. H., and Kim, D. H. (2008) Lactic acid bacteria inhibit proinflammatory cytokine expression and bacterial glycosaminoglycan degradation activity in dextran sulfate sodiuminduced colitic mice. Int. Immunopharmacol. 8, 574-580.   DOI   ScienceOn
14 Kato, I., Yokokura, T., and Mutai, M. (1984) Augmentation of mouse natural killer cell activity by Lactobacillus casei and its surface antigens. Microbiol. Immunol. 27, 209-217.
15 Lane, D. J. (1991) 16S/23S rRNA sequencing. In: Nucleic acid techniques in bacterial systematics. Stackebrandt, E. & Goodfellow, M. (eds) John Wiley, Chichester, pp. 115-175.
16 Lee, J. H., Lee, B., Lee, H. S., Bae, E. A., Lee, H., Ahn, Y. T., Lim, K. S., Huh, C. S., and Kim, D. H. (2009) Lactobacillus suntoryeus inhibits pro-inflammatory cytokine expression and TLR-4-linked NF-$\kappa B$ activation in experimental colitis. Int. J. Colorectal Dis. 24, 231-237.   DOI   ScienceOn
17 Macdonald, T. T. and Monteleone, G. (2005) Immunity, inflammation, and allergy in the gut. Science 307, 1920-1925.   DOI   ScienceOn
18 Majamaa, H. and Isolauri, E. (1997) Probiotics: a novel approach in the management of food allergy. J. Allergy Clin. Immunol. 99, 175-185.
19 Matsubuchi, T., Takagi, A., Matsuzaki, T., Nagaoka, M., Ishikawa, K., Yokokura, T., and Yoshikai, Y. (2003) Lipoteichoic acids from Lactobacillus strains elicit strong tumor necrosis factor alpha-inducing activities in macrophages through Toll-like receptor 2. Clin. Diagn. Lab. Immun. 10, 259-266.
20 Matsumoto, S., Hara, T., Hori, T., Mitsuyama, K., Nagaoka, M., Tomlyasu, N., Suzuki, A., and Sata, M. (2005) Probiotic Lactobacillus-induced improvement in murine chronic inflammatory bowel disease is associated with the down-regulation of pro-inflammatory cytokines in lamina propria mononuclear cells. Clin. Exp. Immunol. 140, 417-426.   DOI   ScienceOn
21 Nathan, C. and Xie, Q. W. (1994) Nitric oxide synthases: roles, tolls and controls. Cell 78, 915-918.   DOI   ScienceOn
22 Menard, S., Candalh, C., Bambou, J. C., Terpend, K., Cerf- Bensussan, N., and Heyman, M. (2004) Lactic acid bacteria secrete metabolites retaining anti-inflammatory properties after intestinal transport. Gut 53, 821-828.   DOI   ScienceOn
23 Morotomi, M. (1996) Properties of Lactobacillus casei Shirota strain as probiotics. Asia Pacific J. Clin. Nutr. 5, 29-30.
24 Narvhus, J. (1996) Probiotiske bakterier-metabolisme in melk. Meieriposten 12, 341-343.
25 Pena, J. A. and Versalovic, J. (2003) Lactobacillus rhamnosus GG decreases TNF-$\alpha$ production in lipopolysaccharideactived murine macrophages by a contact-independent mechanism. Cell Microbiol. 5, 277-285.   DOI   ScienceOn
26 Sadowsky, D. W., Novy, M. J., Witkin, S. S., and Gravett, M. G. (2003) Dexamethasone or interleukin-10 blocks interleukin- 1 beta-induced uterine contractions in pregnant rhesus monkeys. Am. J. Obstet. Gynecol. 188, 252-236.   DOI   ScienceOn
27 Sambrook, J., Fritsch, E. F., and Maniates, T. (1989) Molecular cloning: a laboratory manual, 2nd ed. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, N.Y.
28 Samona, A. and Robinson. R. K. (1991) Enumeration of bifidobacteria in dairy products. J. Soc. Dairy Technol. 44, 64-66.   DOI
29 Sanders, M. E. (1993) Effect of consumption of lactic cultures on human health. In: Advance in Food and Nutrition Research. Kinsella, J. (ed) Academic Press, San Diego, pp. 67-130.
30 Stein, B. and Sutherland, M. S. K. (1998) IL-6 as a drug discovery target. Drug Discov. Today 3, 202-213.   DOI   ScienceOn
31 Ulevitch, R. J. and Tobias. P. S. (1995) Receptor-dependent mechanisms of cell stimulation by bacterial endotoxin. Ann. Rev. Immunol. 13, 437-457.   DOI   ScienceOn
32 Stuehr, D. J. and Marlette, M. A. (1985) Mammalian nitrate biosynthesis: mouse macrophages produce nitrite and nitrate in response to Escherichia coli lipopolysaccharide. Proc. Nat'l. Acad. Sci. USA 82, 7738-7742.   DOI   ScienceOn
33 Stuehr, D. J. and Marlette, M. A. (1987) Induction of nitrite/ nitrate synthesis in murine macrophages by BCG infection, lymphokines or interferon-$\gamma$. J. Immunol. 39, 518-525.
34 Trushin, S. A., Pennington, K. N., Carmona, E. M., Asin, S., Savoy, D. N., Billadeau, D. D., and Paya, C. V. (2003) Protein kinase $C \alpha$ ($PKC \alpha$) acts upstream of PK theta to activate I$\kappa B$ kinase and NF-$\kappa B$ in T lymphocytes. Mol. Cell Biol. 23, 7068-7081.   DOI
35 Wai, P. Y. and Kuo, P. C. (2004) Nitric oxide and endotoxinmediated sepsis: the role of osteopontin. Gene Ther. Mol. Biol. 8, 501-508.
36 Yeganegi, M., Leung, C. G., Martins, A., Kim, S. O., Reid, G., Challis, J. R. G., and Bocking, A. D. (2010) Lactobacillus rhamnosus GR-1-induced IL-10 production in human placental trophoblast cells involves activation of JAK/STAT and MAPK pathways. Reprod. Sci. 17, 1043-1051.   DOI